Kate Sikora is an expert on state health policy.

She assists clients with anticipating and responding to the impacts of state legislative and regulatory developments on their strategic priorities. Her expertise spans Medicaid, state regulation of short-term health plans, tobacco cessation, and utilization management.

Prior to joining Avalere, Kate helped to build the state policy and advocacy program for the American Society of Clinical Oncology, the world's leading professional organization for physicians and oncology professionals.

Kate holds a MBA from the Johns Hopkins University Carey Business School with a focus on healthcare administration and a BA in government and politics from the University of Maryland.

Authored Content

Remote patient monitoring (RPM) provides an opportunity to diagnose and treat patients facing neurological diseases. Given that multiple sclerosis (MS), Parkinson’s disease, and epilepsy require intervention from specialized care teams, effective management of these chronic neurological conditions can be supported through RPM to improve patient outcomes. Although RPM has been shown to be a complement and in some cases an alternative to office-based care, reimbursement and coverage barriers remain.

State healthcare legislation often holds important implications for high-value and high-cost drugs, such as those used to treat cancer patients.

Avalere’s state policy team recently attended the National Academy for State Health Policy’s (NASHP) Annual Conference for 3 days of interactive state health policy discussions and the facilitation of a roundtable on the direction of telehealth in the states.

States are increasingly seeking to improve access and health outcomes for their underserved, rural, or homebound populations, and many are turning to telehealth as a solution.

While the majority of state legislative sessions have adjourned for 2019, at least 11 states (CT, FL, LA, IN, MD, ME, NH, NM, NV, VT, and WA) have enacted laws to create or study coverage protections against pre-existing condition exclusions and coverage of all essential health benefits (EHB) provided for in the Affordable Care Act (ACA).